Daidzein inhibits insulin- or insulin-like growth factor-1-mediated signaling in cell cycle progression of Swiss 3T3 cells

Author(s):  
Kyoichiro Higashi ◽  
Hiroshi Ogawara
2000 ◽  
Vol 68 (8) ◽  
pp. 4531-4538 ◽  
Author(s):  
Brenda A. Wilson ◽  
Lyaylya R. Aminova ◽  
Virgilio G. Ponferrada ◽  
Mengfei Ho

ABSTRACT The intracellularly acting protein toxin of Pasteurella multocida (PMT) causes numerous effects in cells, including activation of inositol 1,4,5-trisphosphate (IP3) signaling, Ca2+ mobilization, protein phosphorylation, morphological changes, and DNA synthesis. The direct intracellular target of PMT responsible for activation of the IP3 pathway is the Gq/11α-protein, which stimulates phospholipase C (PLC) β1. The relationship between PMT-mediated activation of the Gq/11-PLC-IP3pathway and its ability to promote mitogenesis and cellular proliferation is not clear. PMT stimulation of p42/p44 mitogen-activated protein kinase occurs upstream via Gq/11-dependent transactivation of the epidermal growth factor receptor. We have further characterized the effects of PMT on the downstream mitogenic response and cell cycle progression in Swiss 3T3 and Vero cells. PMT treatment caused dramatic morphological changes in both cell lines. In Vero cells, limited multinucleation, nuclear fragmentation, and disruption of cytokinesis were also observed; however, a strong mitogenic response occurred only with Swiss 3T3 cells. Significantly, this mitogenic response was not sustained. Cell cycle analysis revealed that after the initial mitogenic response to PMT, both cell types subsequently arrested primarily in G1and became unresponsive to further PMT treatment. In Swiss 3T3 cells, PMT induced up-regulation of c-Myc; cyclins D1, D2, D3, and E; p21; PCNA; and the Rb proteins, p107 and p130. In Vero cells, PMT failed to up-regulate PCNA and cyclins D3 and E. We also found that the initial PMT-mediated up-regulation of several of these signaling proteins was not sustained, supporting the subsequent cell cycle arrest. The consequences of PMT entry thus depend on the differential regulation of signaling pathways within different cell types.


2001 ◽  
Vol 120 (5) ◽  
pp. A508-A508
Author(s):  
E ZHUKOVA ◽  
J SINNETTSMITH ◽  
A BOLLES ◽  
H WONG ◽  
S YOUNG ◽  
...  

2000 ◽  
Vol 36 (1) ◽  
pp. 101-111 ◽  
Author(s):  
Michael Karas ◽  
Hadar Amir ◽  
Daniel Fishman ◽  
Michael Danilenko ◽  
Shraga Segal ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A508
Author(s):  
Elena Zhukova ◽  
James Sinnett-Smith ◽  
Angela Bolles ◽  
Helen Wong ◽  
Steve Young ◽  
...  

1993 ◽  
Vol 137 (1) ◽  
pp. 99-105 ◽  
Author(s):  
I. Kojima ◽  
H. Mogami ◽  
N. Kawamura ◽  
H. Shibata

ABSTRACT The present study was carried out to examine the effect of activin A on cell-cycle progression induced by insulin-like growth factor-I (IGF-I) in Balb/c 3T3 cells. When activin A was added together with IGF-I to competent cells primed with epidermal growth factor (primed competent cells), both [3H]thymidine incorporation and nuclear labelling induced by IGF-I were inhibited. The inhibition was concentration-dependent and the maximum inhibition was obtained with 1 nmol activin A/l. To ascertain the time in which activin A exerted its inhibitory action, we divided 12 h, the time required for primed competent cells to progress towards the S phase, into four periods and activin A was added during each of the four periods. It was effective when added during either the second (3 to 6 h) or the third period (6 to 9 h) but it did not affect cell-cycle progression when added during the first (0 to 3 h) or the last period (9 to 12 h). We then examined whether activin A affected intracellular events elicited by IGF-I. It did not affect either autophosphorylation of the IGF-I receptor or calcium entry induced by IGF-I. Likewise, it did not cause any change in the radioactivity of 1,2-diacylglycerol (DAG) in cells prelabelled with [3H]myristate while the increase in the mass of DAG induced by IGF-I was markedly reduced by activin A. The dose-response relationship for the activin A-mediated reduction of DAG mass correlated well with that for the activin A-mediated reduction of DNA synthesis. Activin A was effective in reducing DAG mass even when added 3 h after the addition of IGF-I. These results indicate that activin A attenuates cell-cycle progression in the middle of the G1 phase. The results also raise the possibility that reduction of DAG mass may account for the inhibitory effect of activin A on cell-cycle progression. Journal of Endocrinology (1993) 137, 99–105


Sign in / Sign up

Export Citation Format

Share Document